SCHEMBL19600419

SCHEMBL19600419

CC(C)(C)c1ccc(-c2ccc3c4c(cccc24)Oc2cc(-c4cc5c6ccccc6ccc5c5ccccc45)ccc2-3)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.36
KDM4E B2RXH2 1/20 0.35
MAPK1 P28482 1/20 0.35
ATM Q13315 1/20 0.35
CCR4 P51679 1/20 0.32
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
PPARG P37231 2/20 0.31
PPARA Q07869 2/20 0.31
NR1I2 O75469 1/20 0.31
LMNA P02545 1/20 0.31
ADRA2A P08913 1/20 0.31
CYP2D6 P10635 1/20 0.31
ACHE P22303 1/20 0.31
SLC6A2 P23975 1/20 0.31
HTR2A P28223 1/20 0.31
SLC6A4 P31645 1/20 0.31
KCNH2 Q12809 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
KIF11 P52732 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19600428 0.87 MAPK1 (0.40) GPR84KDM4EMAPK1ATMALDH1A1
SCHEMBL19600407 0.81 KDM4E (0.43) GPR84KDM4EMAPK1ATMALDH1A1
SCHEMBL19600435 0.80 MAPK1 (0.40) GPR84KDM4EMAPK1ATMALDH1A1
SCHEMBL17120218 0.80 CA1 (0.39) KDM4EMAPK1ATMALDH1A1MAPT
SCHEMBL17885529 0.79 ALDH1A1 (0.33) GPR84ALDH1A1MAPT
SCHEMBL17120181 0.78 KDM4E (0.38) KDM4EMAPK1ATMALDH1A1MAPT
SCHEMBL17120235 0.78 CA1 (0.37) KDM4EMAPK1ATMALDH1A1MAPT
SCHEMBL17885515 0.78 ALDH1A1 (0.33) GPR84KDM4EMAPK1ATMALDH1A1
SCHEMBL19600405 0.78 KDM4E (0.49) KDM4EMAPK1ATMALDH1A1MAPT
SCHEMBL19600434 0.77 KDM4E (0.36) KDM4EMAPK1ATMALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10573825-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-25 US disclosed
US-20170331051-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-16 US disclosed
US-20170331051-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10573825-B2 Compound and organic light-emitting device including the same CRY1, CRY2, AOX1 GPR84 2471/4885KDM4E 2074/4885MAPK1 2174/4885
US-20170331051-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, AOX1 GPR84 2471/4885KDM4E 2074/4885MAPK1 2174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.